These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19883744)

  • 1. Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome.
    Mannerås L; Fazliana M; Wan Nazaimoon WM; Lönn M; Gu HF; Ostenson CG; Stener-Victorin E
    J Ethnopharmacol; 2010 Feb; 127(2):346-51. PubMed ID: 19883744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labisia pumila extract regulates body weight and adipokines in ovariectomized rats.
    Fazliana M; Wan Nazaimoon WM; Gu HF; Ostenson CG
    Maturitas; 2009 Jan; 62(1):91-7. PubMed ID: 19054635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
    Johansson J; Feng Y; Shao R; Lönn M; Billig H; Stener-Victorin E
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E551-9. PubMed ID: 20663984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labisia pumila var. alata reduces bacterial load by inducing uroepithelial cell apoptosis.
    Fazliana M; Ramos NL; Lüthje P; Sekikubo M; Holm A; Wan Nazaimoon WM; Brauner A
    J Ethnopharmacol; 2011 Jun; 136(1):111-6. PubMed ID: 21524700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
    Mannerås L; Jonsdottir IH; Holmäng A; Lönn M; Stener-Victorin E
    Endocrinology; 2008 Jul; 149(7):3559-68. PubMed ID: 18388196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis.
    Shuid AN; Ping LL; Muhammad N; Mohamed N; Soelaiman IN
    J Ethnopharmacol; 2011 Jan; 133(2):538-42. PubMed ID: 20971181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.
    Seow KM; Juan CC; Ho LT; Hsu YP; Lin YH; Huang LW; Hwang JL
    Hum Reprod; 2007 Apr; 22(4):1100-6. PubMed ID: 17208941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model.
    Fathilah SN; Mohamed N; Muhammad N; Mohamed IN; Soelaiman IN; Shuid AN
    BMC Complement Altern Med; 2013 Sep; 13():217. PubMed ID: 24007208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labisia pumila extract down-regulates hydroxysteroid (11-beta) dehydrogenase 1 expression and corticosterone levels in ovariectomized rats.
    Fazliana M; Gu HF; Östenson CG; Yusoff MM; Wan Nazaimoon WM
    J Nat Med; 2012 Apr; 66(2):257-64. PubMed ID: 21833773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Labisia pumila var alata extracts on the lipid profile, serum antioxidant status and abdominal aorta of high-cholesterol diet rats.
    Dianita R; Jantan I; Jalil J; Amran AZ
    Phytomedicine; 2016 Jul; 23(8):810-7. PubMed ID: 27288916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor-induced rat model of polycystic ovary syndrome.
    Maliqueo M; Benrick A; Marcondes RR; Johansson J; Sun M; Stener-Victorin E
    Exp Physiol; 2017 Jan; 102(1):113-127. PubMed ID: 27790765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.